 | |
| Clinical data | |
|---|---|
| Routes of administration | intramuscular |
| ATC code | |
| Pharmacokinetic data | |
| Eliminationhalf-life | 70–100 hours |
| Excretion | renal |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.011.560 |
| Chemical and physical data | |
| Formula | C19H18N2O3 |
| Molar mass | 322.364 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Kebuzone (orketophenylbutazone) is anonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such asthrombophlebitis andrheumatoid arthritis (RA).[1][2][3]
{{cite book}}: CS1 maint: location missing publisher (link)| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
 | Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it. |
